论文信息 - A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck. - 字舞流文

A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck.

E. Schmidt | D. Rasco | M. Brose | N. Vogelzang | L. Wirth | R. Shumaker | A. Cohn | D. Richards | D. Stepan | C. Dutcus | S. Richey | M. Guo | Matthew H. Taylor